| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.48e-05 | 16 | 61 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.98e-05 | 20 | 61 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.47e-05 | 21 | 61 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 9.13e-05 | 5 | 61 | 2 | GO:0005007 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.33e-04 | 85 | 61 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 2.54e-04 | 8 | 61 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 4.07e-04 | 10 | 61 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 9.40e-04 | 15 | 61 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.39e-03 | 72 | 61 | 3 | GO:0015026 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 5.81e-06 | 321 | 63 | 8 | GO:0010001 | |
| GeneOntologyBiologicalProcess | gliogenesis | 6.56e-06 | 435 | 63 | 9 | GO:0042063 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 1.65e-05 | 104 | 63 | 5 | GO:0007405 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 1.73e-05 | 105 | 63 | 5 | GO:0048708 | |
| GeneOntologyBiologicalProcess | alveolar secondary septum development | 5.49e-05 | 4 | 63 | 2 | GO:0061144 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix disassembly | 5.95e-05 | 25 | 63 | 3 | GO:0010715 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 7.73e-05 | 233 | 63 | 6 | GO:0061351 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.12e-04 | 625 | 63 | 9 | GO:0051960 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.66e-04 | 515 | 63 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | endocytosis | 1.89e-04 | 827 | 63 | 10 | GO:0006897 | |
| GeneOntologyBiologicalProcess | leukotriene transport | 1.91e-04 | 7 | 63 | 2 | GO:0071716 | |
| GeneOntologyBiologicalProcess | contact inhibition | 2.54e-04 | 8 | 63 | 2 | GO:0060242 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 2.54e-04 | 8 | 63 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of cholangiocyte proliferation | 2.54e-04 | 8 | 63 | 2 | GO:1904054 | |
| GeneOntologyBiologicalProcess | detection of cell density | 3.26e-04 | 9 | 63 | 2 | GO:0060245 | |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 3.58e-04 | 110 | 63 | 4 | GO:2000027 | |
| GeneOntologyBiologicalProcess | import into cell | ABCC1 ATP8A1 ARFGAP3 TM9SF4 LRP1 LRP4 LRP6 C4A CUBN LRP1B XKR5 | 3.69e-04 | 1074 | 63 | 11 | GO:0098657 |
| GeneOntologyBiologicalProcess | cobalamin transport | 4.07e-04 | 10 | 63 | 2 | GO:0015889 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 4.07e-04 | 10 | 63 | 2 | GO:1990705 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 4.26e-04 | 48 | 63 | 3 | GO:0043277 | |
| Domain | Ldl_recept_b | 9.40e-08 | 14 | 60 | 4 | PF00058 | |
| Domain | LDLRB | 9.40e-08 | 14 | 60 | 4 | PS51120 | |
| Domain | LY | 1.28e-07 | 15 | 60 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.28e-07 | 15 | 60 | 4 | IPR000033 | |
| Domain | - | 7.28e-06 | 39 | 60 | 4 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 8.06e-06 | 40 | 60 | 4 | IPR023415 | |
| Domain | DUF5050 | 1.01e-05 | 2 | 60 | 2 | IPR032485 | |
| Domain | DUF5050 | 1.01e-05 | 2 | 60 | 2 | PF16472 | |
| Domain | Ldl_recept_a | 1.30e-05 | 45 | 60 | 4 | PF00057 | |
| Domain | - | 1.42e-05 | 46 | 60 | 4 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.42e-05 | 46 | 60 | 4 | IPR011042 | |
| Domain | LDLRA_1 | 1.68e-05 | 48 | 60 | 4 | PS01209 | |
| Domain | LDLRA_2 | 1.83e-05 | 49 | 60 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.83e-05 | 49 | 60 | 4 | IPR002172 | |
| Domain | LDLa | 1.83e-05 | 49 | 60 | 4 | SM00192 | |
| Domain | EGF | 5.24e-05 | 126 | 60 | 5 | PF00008 | |
| Domain | EMP70 | 6.06e-05 | 4 | 60 | 2 | PF02990 | |
| Domain | FGF_rcpt_fam | 6.06e-05 | 4 | 60 | 2 | IPR016248 | |
| Domain | EMP70 | 6.06e-05 | 4 | 60 | 2 | IPR004240 | |
| Domain | cEGF | 7.77e-05 | 26 | 60 | 3 | IPR026823 | |
| Domain | cEGF | 7.77e-05 | 26 | 60 | 3 | PF12662 | |
| Domain | EGF_CA | 1.68e-04 | 86 | 60 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 2.67e-04 | 97 | 60 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.88e-04 | 99 | 60 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.00e-04 | 100 | 60 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.74e-04 | 106 | 60 | 4 | IPR000152 | |
| Domain | Peptidase_S9 | 5.48e-04 | 11 | 60 | 2 | PF00326 | |
| Domain | Peptidase_S9 | 5.48e-04 | 11 | 60 | 2 | IPR001375 | |
| Domain | EGF_CA | 6.37e-04 | 122 | 60 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.77e-04 | 124 | 60 | 4 | IPR001881 | |
| Domain | EGF_3 | 9.40e-04 | 235 | 60 | 5 | PS50026 | |
| Domain | EGF | 9.40e-04 | 235 | 60 | 5 | SM00181 | |
| Domain | EGF-like_dom | 1.22e-03 | 249 | 60 | 5 | IPR000742 | |
| Domain | EGF_1 | 1.35e-03 | 255 | 60 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.50e-03 | 261 | 60 | 5 | IPR013032 | |
| Domain | Growth_fac_rcpt_ | 1.59e-03 | 156 | 60 | 4 | IPR009030 | |
| Domain | EGF_2 | 1.60e-03 | 265 | 60 | 5 | PS01186 | |
| Domain | ABC_membrane | 2.68e-03 | 24 | 60 | 2 | PF00664 | |
| Domain | ABC_TM1F | 3.64e-03 | 28 | 60 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 3.64e-03 | 28 | 60 | 2 | IPR011527 | |
| Domain | ABC_transporter_CS | 8.05e-03 | 42 | 60 | 2 | IPR017871 | |
| Domain | WD40 | 9.60e-03 | 259 | 60 | 4 | PF00400 | |
| Domain | ABC_tran | 1.04e-02 | 48 | 60 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.04e-02 | 48 | 60 | 2 | PS50893 | |
| Domain | WD40 | 1.08e-02 | 268 | 60 | 4 | SM00320 | |
| Pubmed | 3.63e-09 | 11 | 65 | 4 | 24639464 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC1 FAP EMC3 TM9SF2 TM9SF4 LRP1 LRP4 LRP6 C4A FGFR4 NCSTN ZZEF1 LRP1B SLC37A4 WDR62 | 4.46e-09 | 1201 | 65 | 15 | 35696571 |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 6.49e-08 | 21 | 65 | 4 | 21337463 | |
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 3.44e-06 | 2 | 65 | 2 | 26031789 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 3.44e-06 | 2 | 65 | 2 | 15963947 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 30486550 | ||
| Pubmed | FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. | 3.44e-06 | 2 | 65 | 2 | 9716527 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 20093646 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 26431494 | ||
| Pubmed | TM9SF4 is a novel factor promoting autophagic flux under amino acid starvation. | 3.44e-06 | 2 | 65 | 2 | 29125601 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 17957151 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 25982172 | ||
| Pubmed | 4.00e-06 | 126 | 65 | 5 | 17897319 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 17203221 | ||
| Pubmed | The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion. | 1.03e-05 | 3 | 65 | 2 | 18061161 | |
| Pubmed | Metabolism. Differential regulation of mTORC1 by leucine and glutamine. | 1.03e-05 | 3 | 65 | 2 | 25567907 | |
| Pubmed | Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype. | 1.03e-05 | 3 | 65 | 2 | 21139072 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 17075973 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 21561999 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 22343475 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 32111983 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 8083748 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 19393132 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 20093106 | ||
| Pubmed | [Role of PTEN protein in multidrug resistance of prostate cancer cells]. | 2.06e-05 | 4 | 65 | 2 | 18702307 | |
| Pubmed | Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function. | 2.06e-05 | 4 | 65 | 2 | 21471202 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 9664689 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 24030729 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 21383697 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 9212826 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 27154171 | ||
| Pubmed | Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. | 2.06e-05 | 4 | 65 | 2 | 23393200 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 16821592 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 14739301 | ||
| Pubmed | Shh Plays an Inhibitory Role in Cusp Patterning by Regulation of Sostdc1. | 2.06e-05 | 4 | 65 | 2 | 30325689 | |
| Pubmed | Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. | 2.06e-05 | 4 | 65 | 2 | 12373339 | |
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 2.06e-05 | 4 | 65 | 2 | 36142417 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 11759058 | ||
| Pubmed | The FGF system has a key role in regulating vascular integrity. | 2.06e-05 | 4 | 65 | 2 | 18776942 | |
| Pubmed | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. | 2.06e-05 | 4 | 65 | 2 | 17304337 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 16210019 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 12644244 | ||
| Pubmed | Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. | 2.70e-05 | 31 | 65 | 3 | 22076636 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 20383322 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 27206683 | ||
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 3.43e-05 | 5 | 65 | 2 | 15987787 | |
| Pubmed | The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes. | 3.43e-05 | 5 | 65 | 2 | 27078042 | |
| Pubmed | Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. | 3.43e-05 | 5 | 65 | 2 | 16091423 | |
| Pubmed | FGF-dependent regulation of VEGF receptor 2 expression in mice. | 3.43e-05 | 5 | 65 | 2 | 21633168 | |
| Pubmed | Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding. | 3.43e-05 | 5 | 65 | 2 | 16263759 | |
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 3.43e-05 | 5 | 65 | 2 | 9771645 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 21454706 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 29122839 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 20558667 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 28094278 | ||
| Pubmed | mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state. | 3.43e-05 | 5 | 65 | 2 | 23394946 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 19047013 | ||
| Pubmed | TRIM37 deficiency induces autophagy through deregulating the MTORC1-TFEB axis. | 3.43e-05 | 5 | 65 | 2 | 29940807 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 9013630 | ||
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 3.43e-05 | 5 | 65 | 2 | 11566361 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.96e-05 | 101 | 65 | 4 | 23382219 | |
| Pubmed | 5.02e-05 | 38 | 65 | 3 | 26595272 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 10572038 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 9010207 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 16365308 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 18753255 | ||
| Pubmed | Regulation of fibroblast growth factor-23 signaling by klotho. | 5.13e-05 | 6 | 65 | 2 | 16436388 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 19232523 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 19966287 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 29720668 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 37091972 | ||
| Pubmed | The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. | 5.13e-05 | 6 | 65 | 2 | 18497260 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 19515808 | ||
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 5.13e-05 | 6 | 65 | 2 | 24026051 | |
| Pubmed | Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. | 7.18e-05 | 7 | 65 | 2 | 8626374 | |
| Pubmed | Comparative analysis of the expression patterns of TM9SF family members in mice. | 7.18e-05 | 7 | 65 | 2 | 38719197 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 34093381 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 16772167 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 34847079 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 8959336 | ||
| Pubmed | Putative tyrosine kinases expressed in K-562 human leukemia cells. | 7.18e-05 | 7 | 65 | 2 | 2247464 | |
| Pubmed | Expression patterns of FGF receptors in the developing mammalian cochlea. | 7.18e-05 | 7 | 65 | 2 | 20131355 | |
| Pubmed | ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner. | 9.56e-05 | 8 | 65 | 2 | 11940572 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 7657660 | ||
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 18187602 | ||
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 17623664 | ||
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 15802388 | ||
| Pubmed | Syndecan-4 dependent FGF stimulation of mouse vibrissae growth. | 9.56e-05 | 8 | 65 | 2 | 16989989 | |
| Pubmed | 1.22e-04 | 51 | 65 | 3 | 26764350 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 23986861 | ||
| Pubmed | Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. | 1.23e-04 | 9 | 65 | 2 | 15830353 | |
| Pubmed | Dynamic activation of Wnt, Fgf, and Hh signaling during soft palate development. | 1.23e-04 | 9 | 65 | 2 | 31613912 | |
| Pubmed | Integration of FGF and TWIST in calvarial bone and suture development. | 1.23e-04 | 9 | 65 | 2 | 10751173 | |
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 11335076 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 15229180 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 12817007 | ||
| Pubmed | Hypertonicity activates Na+/H+ exchange through Janus kinase 2 and calmodulin. | 1.23e-04 | 9 | 65 | 2 | 12626508 | |
| Pubmed | Identification of the ligands of protein interaction domains through a functional approach. | 1.23e-04 | 9 | 65 | 2 | 17124247 | |
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 24337580 | ||
| Pubmed | p62 is a key regulator of nutrient sensing in the mTORC1 pathway. | 1.23e-04 | 9 | 65 | 2 | 21981924 | |
| Interaction | PID1 interactions | 1.27e-06 | 27 | 61 | 4 | int:PID1 | |
| Interaction | LRPAP1 interactions | 1.73e-05 | 180 | 61 | 6 | int:LRPAP1 | |
| Interaction | ANKRD36B interactions | 3.26e-05 | 60 | 61 | 4 | int:ANKRD36B | |
| Interaction | SCGB1D1 interactions | 5.13e-05 | 133 | 61 | 5 | int:SCGB1D1 | |
| GeneFamily | Low density lipoprotein receptors | 1.77e-08 | 13 | 42 | 4 | 634 | |
| GeneFamily | Transmembrane 9 superfamily members | 3.15e-05 | 4 | 42 | 2 | 1239 | |
| GeneFamily | ATP binding cassette subfamily C | 4.04e-04 | 13 | 42 | 2 | 807 | |
| GeneFamily | WD repeat domain containing | 3.13e-03 | 262 | 42 | 4 | 362 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.89e-03 | 40 | 42 | 2 | 321 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP | 9.50e-06 | 200 | 64 | 6 | M9478 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-06 | 164 | 65 | 5 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-06 | 164 | 65 | 5 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 198 | 65 | 5 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-05 | 199 | 65 | 5 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Glia_progenitor_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-05 | 200 | 65 | 5 | 859f98f63797087e7df18be632de153009b6cab1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 123 | 65 | 4 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 6.01e-05 | 145 | 65 | 4 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-7|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 6.01e-05 | 145 | 65 | 4 | 88090a226ddfa6df59976f025bf0fd84ca0f72ef | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 6.01e-05 | 145 | 65 | 4 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 7.79e-05 | 155 | 65 | 4 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 166 | 65 | 4 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 169 | 65 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-04 | 171 | 65 | 4 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 1.16e-04 | 172 | 65 | 4 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 173 | 65 | 4 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.22e-04 | 174 | 65 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 178 | 65 | 4 | b1357ceb84b83fab53c0394c1af73cbd009f571a | |
| ToppCell | Globus_pallidus-Macroglia|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.36e-04 | 179 | 65 | 4 | ab50f711b004b96107f813c9a2526ec21d1c8027 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 181 | 65 | 4 | 9dc0563453e24c9d1d975e2e0e1e272487e19908 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.42e-04 | 181 | 65 | 4 | 070ae3f3fe0e177fabcf34e64a0f158b01354837 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 181 | 65 | 4 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 181 | 65 | 4 | 14c2dd946e89ba578711c2d25935b6b3d319b701 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 181 | 65 | 4 | c5843b89f3d362e236ff76c3279518a2fdfc1f75 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 181 | 65 | 4 | fcefb5902416c004631f4f8dd5c8f99fe3bd90bc | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 183 | 65 | 4 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 71 | 65 | 3 | cf4c8715c2bd77fc86e45cc01bcc7aa6044e091d | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.54e-04 | 185 | 65 | 4 | 2c07991e0907ded67e21ab2e66be21695842ed01 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 186 | 65 | 4 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-04 | 186 | 65 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 187 | 65 | 4 | 3827fa80e558b642f3e0036f5ee1a8b69f437e30 | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 187 | 65 | 4 | 1bf696eb03422ea507d3efe58dda1d442a65225d | |
| ToppCell | droplet-Lung-3m-Endothelial-venous_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 187 | 65 | 4 | ebe4d1216cc0d4c079b413d5a5460cfd3a4af922 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 187 | 65 | 4 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 187 | 65 | 4 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.67e-04 | 189 | 65 | 4 | 6687a93ac8540ece5fd762f6f77c1f25f159195b | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 1.67e-04 | 189 | 65 | 4 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 191 | 65 | 4 | 509230f50568e5a8ecf08edc4d58f9e2aa96efe9 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.74e-04 | 191 | 65 | 4 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 191 | 65 | 4 | 0b3dbbc35d9970d3c749aef16dda59886b960e3d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 192 | 65 | 4 | d2161842a38146261847fc9061ba9322e0f087e0 | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 192 | 65 | 4 | 39afea574725ce0c67afdd79facdb34f819a828d | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 192 | 65 | 4 | 597db951b1fbc37db22134c3d27d3ec4ceaa85f7 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 1.78e-04 | 192 | 65 | 4 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 192 | 65 | 4 | bc275a9eccb1c7a46fd58b15ca5acdd9f7495842 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 193 | 65 | 4 | b32533afeff1905e188becaa09079e9699722e4b | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 193 | 65 | 4 | 2ff573ba2c74583ed1cb071a3bbc01bb71117e5f | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 193 | 65 | 4 | e164f6403a8b541ced08a6feec915d2e855036ea | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.85e-04 | 194 | 65 | 4 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.92e-04 | 196 | 65 | 4 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 196 | 65 | 4 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | 356C-Endothelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 197 | 65 | 4 | f20eda534b2b28986790b28ce150ca3ba067593a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 199 | 65 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 200 | 65 | 4 | 29f82e2ad2f1888b6b236a4392b88a84351b8ddc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 200 | 65 | 4 | 1598a9e8efa72fda7d12df07e7716b326cdf1d5e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Astrocyte|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 200 | 65 | 4 | 4fe3b2d80c567c18621bff3341f9a73578c81621 | |
| Drug | monatepil | 1.69e-08 | 29 | 64 | 5 | CID000060810 | |
| Disease | bone disease (implicated_via_orthology) | 3.65e-05 | 5 | 57 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | body fat percentage | 4.20e-05 | 488 | 57 | 7 | EFO_0007800 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 7.22e-05 | 364 | 57 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | high grade glioma (implicated_via_orthology) | 8.56e-05 | 44 | 57 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | glutaroyl carnitine measurement | 2.82e-04 | 13 | 57 | 2 | EFO_0021005 | |
| Disease | Malformations of Cortical Development | 3.29e-04 | 14 | 57 | 2 | C1955869 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 3.29e-04 | 14 | 57 | 2 | EFO_0020941 | |
| Disease | Cortical Dysplasia | 3.29e-04 | 14 | 57 | 2 | C0431380 | |
| Disease | Testicular Germ Cell Tumor | 3.29e-04 | 14 | 57 | 2 | C1336708 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.79e-04 | 15 | 57 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 3.79e-04 | 15 | 57 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.79e-04 | 15 | 57 | 2 | C0154091 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 4.32e-04 | 16 | 57 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | glutarylcarnitine (C5-DC) measurement | 4.89e-04 | 17 | 57 | 2 | EFO_0800030 | |
| Disease | Carcinoma of bladder | 5.50e-04 | 18 | 57 | 2 | C0699885 | |
| Disease | body weight | 6.54e-04 | 1261 | 57 | 9 | EFO_0004338 | |
| Disease | Psychoses, Drug | 7.52e-04 | 21 | 57 | 2 | C0033937 | |
| Disease | psychosis predisposition measurement | 1.16e-03 | 26 | 57 | 2 | EFO_0008337 | |
| Disease | type 1 diabetes mellitus | 1.24e-03 | 242 | 57 | 4 | MONDO_0005147 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 1.34e-03 | 28 | 57 | 2 | DOID:0050866 (is_implicated_in) | |
| Disease | Polydactyly | 1.52e-03 | 117 | 57 | 3 | C0152427 | |
| Disease | vitamin B12 measurement | 1.75e-03 | 32 | 57 | 2 | EFO_0004620 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSFSSWDDSSDSYWK | 366 | Q9NP61 | |
| DTSIQLYWKWFVSHF | 2371 | Q7Z2Y8 | |
| YTHQSDVWSFGILLW | 666 | P22455 | |
| LSDIEWHIYQDWHSF | 161 | Q16854 | |
| SWSSAIQSWYDEILD | 106 | P16562 | |
| AGLETSYWTWFSHIA | 996 | Q9Y2Q0 | |
| VFTRWHYSEWSQCSR | 966 | P59510 | |
| VSWHSEYKDSAWIFL | 26 | Q9Y388 | |
| RAAVYVGSFSWWTTD | 81 | Q8N684 | |
| SSTEYSTWTESRWKD | 641 | Q92542 | |
| ESTWWFKSFFHSEPV | 51 | Q8WWR9 | |
| DGESWLSRFSYAWLA | 216 | Q5T3U5 | |
| LSFRWTASEGELSWY | 1101 | P23467 | |
| SIDCTLTFSHPTWYW | 216 | P35372 | |
| YHRAWDTLYWTSSTT | 2276 | Q9NZR2 | |
| SWWIITHVASFYKFD | 351 | Q6ZRQ5 | |
| HRGWDTLYWTSYTTS | 2291 | Q07954 | |
| STSSYRKVTWHWEAS | 91 | Q9H9K5 | |
| VTWADFYWEICSTTL | 146 | O60760 | |
| DFSSYADSLWWGTIT | 266 | P56696 | |
| WSCAWSLSIHAYHSF | 186 | Q8NA75 | |
| VSSSISTYWDWSDSE | 121 | Q6PEV8 | |
| TLFEDILYWTDWSTH | 231 | O75581 | |
| ILYWTDWSTHSILAC | 236 | O75581 | |
| WAKQSWYLSASSAEL | 676 | Q5JSP0 | |
| ASWFTFSIYEIHWVC | 41 | P0DTE2 | |
| FYLHSLIWTCAGDWS | 11 | A8MZH6 | |
| CYWWLKSSHGSAFEL | 1191 | O60494 | |
| TIAKHYSWSTAFWVA | 386 | O43826 | |
| AWSKDTYSPDEHFWA | 326 | Q9P109 | |
| TCSFYDHALHLWEWE | 436 | Q9BTV6 | |
| WHSYYLKSAWNSILA | 156 | O60883 | |
| LSLAWLTYDWNTHSQ | 51 | Q6ZPD8 | |
| YESWTRETESTWLTY | 16 | Q8WXS3 | |
| SSVAYAVSAIAHWDW | 126 | Q96P70 | |
| CWHDNRLYSASWDST | 721 | Q92636 | |
| LDASWVSSASWYFLN | 161 | Q9P0I2 | |
| WSAVTSHTAYWSSLD | 861 | Q8NEL9 | |
| YTHQSDVWSFGVLLW | 671 | P22607 | |
| SSLWDWYTSYLFHPI | 456 | O00237 | |
| YAAWLSRDSSTWLTA | 1066 | P0C0L4 | |
| YSAATEHDRSWYKAW | 1776 | P42345 | |
| HVSALASNYWLSLWT | 986 | P33527 | |
| SEARWTTTWYGSLSF | 31 | Q9NRJ1 | |
| WTVHNASSLLTYDSW | 631 | Q9UGT4 | |
| HAWAQLTFWEASQLY | 76 | Q6UW68 | |
| STQFSHHWYLTDWKS | 631 | Q5HYW2 | |
| DYTWLWGSFSCRFTH | 116 | O15218 | |
| YTCYEHVWTLSWSTQ | 841 | P08F94 | |
| WTLHLSERADWQYSS | 46 | Q5VST6 | |
| IASSDYYFSWLTWVT | 286 | Q12884 | |
| NWLHSYFHKWSAETS | 471 | Q9NUW8 | |
| SLTYWEELATEWSLT | 651 | Q6GYQ0 | |
| TYSVHWEESDIKWAS | 251 | Q92544 | |
| FRTSIWDETLYKAWS | 221 | Q5VZM2 | |
| WYHRFSSDFDELSGW | 371 | P02549 | |
| WFVVLTYAWHTSFKA | 331 | Q99835 | |
| YSSASFWAWLALGFS | 46 | Q9BTX3 | |
| KVWSELFHSSYVWNV | 396 | O43379 | |
| LCAEDYHWQWRSFLT | 581 | Q99805 | |
| VSDASAIWYWSLLTS | 391 | O43149 | |
| PDFVNSYASWWSSHV | 461 | Q658N2 | |
| TLFSWSSLSWALVSY | 146 | Q6UX68 | |
| LAWLEHSSASYFTEW | 1151 | Q5TIE3 | |
| ITVFEDSLYWTDWHT | 646 | O75096 | |
| DSLYWTDWHTKSINS | 651 | O75096 | |
| IYEFWENSSVWNSHL | 301 | Q8N987 |